BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 3034214)

  • 1. Chemically purified serum factor can induce both Epstein-Barr virus antigen synthesis and cell differentiation.
    Anisimová E; Roubalová K; Bauer G; Roubal J
    Arch Virol; 1987; 94(3-4):309-14. PubMed ID: 3034214
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of activated serum factor on the induction of Epstein-Barr virus antigens and cell differentiation.
    Roubalová K; Anisimová E; Roubal J
    Arch Virol; 1985; 85(1-2):85-94. PubMed ID: 2990391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of n-butyrate and phorbol ester (TPA) on induction of Epstein-Barr virus antigens and cell differentiation.
    Anisimová E; Prachová K; Roubal J; Vonka V
    Arch Virol; 1984; 81(3-4):223-37. PubMed ID: 6089703
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced expression of Epstein-Barr virus early antigens by antitubulin agents in a latently infected human lymphoblastoid cell line.
    Fujita J; Yoshida O; Tokuda H; Sugawara K; Ito Y
    Experientia; 1985 Mar; 41(3):372-3. PubMed ID: 2982647
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Suppressive effect of CDDP on induction of the Epstein-Barr virus antigen synthesis by n-butyrate].
    Furukawa M; Kato C; Kamide M; Umeda R
    Nihon Jibiinkoka Gakkai Kaiho; 1989 Feb; 92(2):189-93. PubMed ID: 2545850
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of chemical Epstein-Barr virus induction by dimethyl sulfoxide and related polar compounds.
    Yanase S; Sugawara K
    Intervirology; 1989; 30(3):163-8. PubMed ID: 2546900
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of n-butyrate on Epstein-Barr virus-carrying lymphoma lines.
    Anisimová E; Saemundsen AK; Roubal J; Vonka V; Klein G
    J Gen Virol; 1982 Jan; 58 Pt 1():163-71. PubMed ID: 6292341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhancement of Epstein-Barr virus membrane protein (LMP) expression by serum, TPA, or n-butyrate in latently infected Raji cells.
    Boos H; Berger R; Kuklik-Roos C; Iftner T; Mueller-Lantzsch N
    Virology; 1987 Jul; 159(1):161-5. PubMed ID: 3037776
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of virus enzymes by phorbol esters and n-butyrate in Epstein-Barr virus genome-carrying Raji cells.
    Nutter LM; Grill SP; Li JS; Tan RS; Cheng YC
    Cancer Res; 1987 Aug; 47(16):4407-12. PubMed ID: 3038311
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative analysis of the cooperative effect between inducers of Epstein-Barr virus antigen synthesis.
    Bauer G
    J Gen Virol; 1983 Jun; 64 (Pt 6)():1337-46. PubMed ID: 6304236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of n-butyrate on superinfection of Raji lymphoblastoid cell line by Epstein-Barr virus.
    Roubal J; Roubalová K
    Acta Virol; 1985 Mar; 29(2):162-5. PubMed ID: 2860802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epstein-Barr virus-specific DNA polymerase in virus-nonproducer Raji cells.
    Ooka T; Lenoir GM; Decaussin G; Bornkamm GW; Daillie J
    J Virol; 1986 May; 58(2):671-5. PubMed ID: 3009879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential effect of TPA and n-butyrate on induction of Ii and EBV antigens in the P3HR-1 lymphoblastoid cell line.
    Sairenji T; Spiro RC; Humphreys RE
    Hematol Oncol; 1984; 2(4):381-9. PubMed ID: 6098544
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of antitumor promoting activity in Raji cells carrying Epstein-Barr virus genome by immunoblotting analysis.
    Kondo A; Morimoto T; Okazaki K
    Biosci Biotechnol Biochem; 1998 Feb; 62(2):377-9. PubMed ID: 9532799
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epstein-Barr virus induction by a serum factor. I. Induction and cooperation with additional inducers.
    Bauer G; Höfler P; Zur Hausen H
    Virology; 1982 Aug; 121(1):184-94. PubMed ID: 6287718
    [No Abstract]   [Full Text] [Related]  

  • 16. Ultrastructural studies on cell fusion induced by Epstein-Barr virus or N-butyrate and 12-O-tetradecanoylphorbol-13-acetate. Brief report.
    Asai S; Bayliss GJ; Wolf H; Namikawa I; Ito Y
    Arch Virol; 1985; 86(3-4):327-33. PubMed ID: 2998304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intracellular synthesis of Epstein-Barr virus membrane antigen gp350/220. Inhibitory effect of monensin on its expression.
    Bertoni G; Nguyen QV; Humphreys RE; Sairenji T
    Intervirology; 1989; 30(2):61-73. PubMed ID: 2542183
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epstein-Barr virus replication in interferon-treated cells.
    Sharp NA; Arrand JR; Clemens MJ
    J Gen Virol; 1989 Sep; 70 ( Pt 9)():2521-6. PubMed ID: 2550580
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunofluorescence microscopy and flow cytometry characterization of chemical induction of latent Epstein-Barr virus.
    Jenson HB; Grant GM; Ench Y; Heard P; Thomas CA; Hilsenbeck SG; Moyer MP
    Clin Diagn Lab Immunol; 1998 Jan; 5(1):91-7. PubMed ID: 9455888
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of the gene product encoded by the PstI repeats (IR4) of the Epstein-Barr virus genome.
    Nuebling CM; Mueller-Lantzsch N
    Virology; 1991 Nov; 185(1):519-23. PubMed ID: 1656605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.